Treatment of Hereditary Angioedema: items that need to be addressed in practice parameter
<p>Abstract</p> <p>Background</p> <p>Hereditary Angioedema (HAE) is a rare, autosomal dominant (AD) disorder caused by a C1 esterase inhibitor (C1-inh) deficiency or qualitative defect. Treatment of HAE in many parts of the world fall short and certain items need to be...
Main Authors: | Dagen Callie, Craig Timothy J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Online Access: | http://www.aacijournal.com/content/6/1/11 |
Similar Items
-
New treatments addressing the pathophysiology of hereditary angioedema
by: Davis Alvin E
Published: (2008-04-01) -
Treatment of hereditary angioedema with plasma-derived C1 inhibitor
by: Michael J Prematta, et al.
Published: (2008-08-01) -
Hereditary angioedema: what the gastroenterologist needs to know
by: Ali MA, et al.
Published: (2014-11-01) -
Hereditary Angioedema
by: A.P. Volokha
Published: (2014-03-01) -
Hereditary angioedema
by: Helen Lesser, et al.
Published: (2021-07-01)